“…In contrast to secondary gastric NHL, unifocal growth pattern is the most important endoscopic finding in primary gastric NHL. A unifocal growth pattern facilitates local radical treatment strategies, such as surgery, which may be associated with prolonged remission and a more favorable prognosis [10,26] . As the part of diagnostic procedures, we used abdominal CT in concordance to modified Ann Arbor staging system.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to primary gastric NHL, secondary involvement of the GI tract by nodal NHL, which occurs in 20% to 60% of newly diagnosed cases, reflects disseminated disease that necessitates systemic treatment strategies [9,10] . Studies analyzing the incidence of secondary gastric NHL revealed a great discrepancy between the frequencies of GI involvement diagnosed before treatment as opposed to postmortem findings.…”
AIM:To determine clinical characteristics and treatment outcome of gastric lymphoma after chemotherapy and immuno-chemotherapy.
METHODS:Thirty four patients with primary gastric mucosa associated lymphoid tissue (MALT) lymphoma (Ann Arbor stages Ⅰ to Ⅳ) were enrolled. All had upper gastric endoscopy, abdominal ultrasonography, CT and H pylori status assessment (histology and serology). After anti-H pylori treatment and initial chemotherapy, patients were re-examined every 4 mo.
RESULTS:Histological regression of the lymphoma was complete in 22/34 (64.7%) and partial in 9 (26.5%) patients. Median follow up time for these 31 responders was 60 mo (range 48-120). No regression was noted in 3 patients. Among the 25 (73.5%) H pylori positive patients, the eradication rate was 100%.
CONCLUSION:Using univariate analysis, predictive factors for overall survival were international prognostic index (IPI) score, hemoglobin level, erythrocyte sedimentation rate (ESR), and platelet numbers (P < 0.005). In addition to this, Cox proportion hazard model differentiate IPI score, ESR, and platelets as predictors of survival.
“…In contrast to secondary gastric NHL, unifocal growth pattern is the most important endoscopic finding in primary gastric NHL. A unifocal growth pattern facilitates local radical treatment strategies, such as surgery, which may be associated with prolonged remission and a more favorable prognosis [10,26] . As the part of diagnostic procedures, we used abdominal CT in concordance to modified Ann Arbor staging system.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to primary gastric NHL, secondary involvement of the GI tract by nodal NHL, which occurs in 20% to 60% of newly diagnosed cases, reflects disseminated disease that necessitates systemic treatment strategies [9,10] . Studies analyzing the incidence of secondary gastric NHL revealed a great discrepancy between the frequencies of GI involvement diagnosed before treatment as opposed to postmortem findings.…”
AIM:To determine clinical characteristics and treatment outcome of gastric lymphoma after chemotherapy and immuno-chemotherapy.
METHODS:Thirty four patients with primary gastric mucosa associated lymphoid tissue (MALT) lymphoma (Ann Arbor stages Ⅰ to Ⅳ) were enrolled. All had upper gastric endoscopy, abdominal ultrasonography, CT and H pylori status assessment (histology and serology). After anti-H pylori treatment and initial chemotherapy, patients were re-examined every 4 mo.
RESULTS:Histological regression of the lymphoma was complete in 22/34 (64.7%) and partial in 9 (26.5%) patients. Median follow up time for these 31 responders was 60 mo (range 48-120). No regression was noted in 3 patients. Among the 25 (73.5%) H pylori positive patients, the eradication rate was 100%.
CONCLUSION:Using univariate analysis, predictive factors for overall survival were international prognostic index (IPI) score, hemoglobin level, erythrocyte sedimentation rate (ESR), and platelet numbers (P < 0.005). In addition to this, Cox proportion hazard model differentiate IPI score, ESR, and platelets as predictors of survival.
“…Isaacson and Wright [24] first introduced the MALT concept, describing the lesion in gastrointestinal tract, thyroid gland, salivary gland, and ovaries. The same year, Warren and Marshall [39] discovered in patients with gastric non-Hodgkin's lymphoma a microorganism which produces urease, named Helicobacter pylori (HP).…”
Although the impact of gastroscopy as a diagnostic tool in the patients of our study was of limited value, due to the nonspecific gross pattern of gastric MALT lymphomas, it should be maintained in the diagnostic intervention of the upper GI tract pathologies.
“…Clinical symptoms of primary gastric lymphoma are vague and varied, with abdominal pain being the most common complaint, followed by dyspepsia, vomiting and gastric bleeding [48][49][50][51] . Constitutional B symptoms are exceedingly uncommon.…”
Gastric mucosa associated lymphoid tissue (MALT) lymphoma has recently been incorporated into the World Health Organization (WHO) lymphoma classification, termed as extranodal marginal zone B-cell lymphoma of MALT-type. In about 90% of cases this lymphoma is associated with H pylori infection which has been clearly shown to play a causative role in lymphomagenesis. Although much knowledge has been gained in defining the clinical features, natural history, pathology, and molecular genetics of the disease in the last decade, the optimal treatment approach for gastric MALT lymphomas, especially locally advanced cases, is still evolving. In this review we focus on data for the therapeutic, stage dependent management of gastric MALT lymphoma. Hence, the role of eradication therapy, surgery, chemotherapy and radiotherapy is critically analyzed. Based on these data, we suggest a therapeutic algorithm that might help to better stratify patients for optimal treatment success.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.